tiprankstipranks
Trending News
More News >
Rein Therapeutics (RNTX)
NASDAQ:RNTX
US Market

Rein Therapeutics (RNTX) Technical Analysis

Compare
1,196 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Rein Therapeutics’s (RNTX) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Rein Therapeutics is a Buy.
Rein Therapeutics’s (RNTX) 20-Day exponential moving average is 1.85, while Rein Therapeutics’s (RNTX) share price is $1.7, making it a Sell.
Rein Therapeutics’s (RNTX) 50-Day exponential moving average is 2.02, while Rein Therapeutics’s (RNTX) share price is $1.7, making it a Sell.

Rein Therapeutics (RNTX) Pivot Points

Apr 07, 2025, 12:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.46
1.60
1.69
1.83
1.92
2.06
2.15
Fibonacci
1.60
1.69
1.75
1.83
1.92
1.98
2.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rein Therapeutics (RNTX) Moving Averages

Apr 07, 2025, 12:55 PM
Period
Simple
Exponential
MA5
1.73Sell
1.72Sell
MA10
1.75Sell
1.76Sell
MA20
1.86Sell
1.85Sell
MA50
2.07Sell
2.02Sell
MA100
2.23Sell
2.28Sell
MA200
2.61Sell
2.70Sell
Rein Therapeutics’s (RNTX) 10-Day exponential moving average is 1.76, while Rein Therapeutics’s (RNTX) share price is $1.7, making it a Sell.
Rein Therapeutics’s (RNTX) 100-Day exponential moving average is 2.28, while Rein Therapeutics’s (RNTX) share price is $1.7, making it a Sell.
Rein Therapeutics’s (RNTX) stock price is $1.7 and Rein Therapeutics’s (RNTX) 50-day simple moving average is 2.07, creating a Sell signal.
Rein Therapeutics’s (RNTX) stock price is $1.7 and Rein Therapeutics’s (RNTX) 100-day simple moving average is 2.23, creating a Sell signal.
Rein Therapeutics’s (RNTX) stock price is $1.7 and Rein Therapeutics’s (RNTX) 200-day simple moving average is 2.61, creating a Sell signal.

Rein Therapeutics (RNTX) Technical Indicators

Apr 07, 2025, 12:55 PM
Name
Value
Implied Action
RSI (14)
41.40
Neutral
STOCH (9,6)
25.00
Neutral
STOCHRSI (14)
23.40
Neutral
MACD (12,26)
-0.11
Buy
ADX (14)
10.91
Buy
Williams %R
-74.47
Buy
CCI (14)
-89.83
Neutral
ATR (14)
0.21
-
Ultimate Oscillator
27.83
Sell
ROC
-16.26
Sell
Rein Therapeutics’s (RNTX) Relative Strength Index (RSI) is 41.40, creating a Neutral signal.
Rein Therapeutics’s (RNTX) Trend Strength Indicator (ADX) is 10.91, creating a Buy signal.
Rein Therapeutics’s (RNTX) Commodity Channel Index (CCI) is -89.83, creating a Neutral signal.
Rein Therapeutics’s (RNTX) Price Rate of Change (ROC) is -16.26, creating a Sell signal.

FAQ

Is RNTX a Buy, Hold, or Sell?
Based on RNTX’s technical indicators, RNTX is a Strong Sell.
    What is RNTX’s RSI (14)?
    RNTX’s RSI (14) is 41.40, which suggests RNTX is a Neutral.
      What is RNTX’s MACD?
      RNTX’s MACD is -0.11, which suggests RNTX is a Buy.
        What is RNTX’s 5-day moving average?
        RNTX’s 5-day moving average is 1.73, which suggests RNTX is a Sell.
          What is RNTX’s 20-day moving average?
          RNTX 20-day moving average is 1.86, which suggests RNTX is a Sell.
            What is RNTX’s 50-day moving average?
            RNTX’s 50-day moving average is 2.07, which suggests RNTX is a Sell.
              What is RNTX’s 200-day moving average?
              RNTX’s 200-day moving average is 2.61, which suggests RNTX is a Sell.
                What is RNTX’s Williams % R (14)?
                RNTX’s Williams % R (14) is -74.47, which suggests RNTX is a Buy.
                  What is RNTX’s CCI (14)?
                  RNTX’s CCI (14) is -89.83, which suggests RNTX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis